Panacea Biotec gets CDR EG approval for Corporate Debt Restructuring proposal

Image
Capital Market
Last Updated : Sep 29 2014 | 12:00 PM IST

On 24 Septmeber 2014

Panacea Biotec announced that the Corporate Debt Restructuring Empowered Group (CDR EG) had in its meeting held on 09 September 2014, approved the Company's Corporate Debt Restructuring (CDR) proposal which was referred to CDR Cell on 21 December 2013 and admitted by CDR EG on 24 January 2014 and the LOA dated 24 September 2014 had been issued by CDR EG in this regard.

Powered by Capital Market - Live News

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 29 2014 | 11:25 AM IST

Next Story